Dermapharm Holding SE(DMPHF)
$42.95-0.11 (-0.26%)
DMPHF
Dermapharm Holding SE financials statements
$42.95
At close:-0.11 (-0.26%)
Dermapharm Holding SE (DMPHF) Income Statement
0 Followers
Dermapharm Holding SE Income Statement
Last quarter (Q2 2026), Dermapharm Holding SE's total revenue was €285.15M, an increase of 4.78% from the same quarter last year. In Q2, Dermapharm Holding SE's net income was €23.22M. See Dermapharm Holding SE’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| € 1.16B | € 1.18B | € 1.14B | € 1.02B | € 942.91M | |
| € 391.71M | € 767.07M | € 719.16M | € 660.83M | € 620.69M | |
| € 169.96M | € 550.14M | € 536.27M | € 418.78M | € 333.65M | |
| Depreciation and Amortization | € 92.56M | € 86.78M | € 104.59M | € 101.18M | € 55.16M |
| € 314.31M | € 317.20M | € 265.55M | € 329.81M | € 356.97M | |
| € 221.75M | € 216.93M | € 182.89M | € 243.69M | € 298.47M | |
| € -38.24M | € -44.93M | € -76.90M | € -27.39M | € -5.49M | |
| € 183.51M | € 172.00M | € 106.00M | € 216.30M | € 292.98M | |
| € 132.41M | € 113.79M | € 62.37M | € 134.24M | € 209.58M | |
| Per Share Metrics | |||||
| Basic EPS | € 2.46 | € 2.11 | € 1.16 | € 2.49 | € 3.89 |
| Diluted EPS | € 2.46 | € 2.11 | € 1.16 | € 2.49 | € 3.89 |
| Weighted Average Shares Outstanding | 53.84M | 53.84M | 53.84M | 53.84M | 53.84M |
| Weighted Average Shares Outstanding (Diluted) | 53.84M | 53.84M | 53.84M | 53.84M | 53.84M |
Currency in EUR
